On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...